Samsrita Labs Ltd
Samsrita Labs Ltd (SAMSRITA) last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-0.19 crore. The next scheduled event is an EGM on 26 Oct 2026. The stock last traded at ₹11, a market capitalisation of ₹25.1 crore. Over the past 52 weeks the stock has ranged between ₹10.2 and ₹25.3. Figures are as of 6 Oct 2026 and are not real time.
Samsrita Labs Ltd share price and key metrics
- Current price
- ₹11
- Market cap
- ₹25.1 cr
- Book value
- ₹5.16
- ROE
- -68.8%
- ROCE
- -62.4%
- Dividend yield
- 0.00%
- 52w high / low
- 25.3/10.2
Metrics as of 6 Oct 2026. Not real time.
Track Samsrita Labs Ltd
Cruxal reads every Samsrita Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Samsrita Labs Ltd growth and returns
- 10 Years
- %
- 5 Years
- 15%
- 3 Years
- 0%
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -2814%
- 10 Years
- 3%
- 5 Years
- -20%
- 3 Years
- -12%
- 1 Year
- -38%
- 10 Years
- -13%
- 5 Years
- -13%
- 3 Years
- -24%
- Last Year
- -69%
Samsrita Labs Ltd quarterly results
| ₹ crore | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2024 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 |
| Expenses | 0.07 | 0.08 | 0.06 | 0 | 4.93 | 3.36 | 0.17 | 0.31 |
| Operating profit | -0.07 | -0.08 | -0.06 | 0 | -4.93 | -3.36 | -0.15 | -0.31 |
| OPM % | — | — | — | — | — | — | -750.00% | — |
| Other income | 0.04 | 0.04 | 0.04 | 0 | 0 | 0 | 0.03 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.03 | -0.04 | -0.02 | 0 | -4.93 | -3.36 | -0.12 | -0.31 |
| Tax % | -66.67% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -0.01 | -0.04 | -0.02 | 0 | -4.55 | -2.94 | -0.48 | -0.19 |
| EPS (₹) | -0.01 | -0.03 | -0.01 | 0.00 | -2.00 | -1.29 | -0.21 | -0.08 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Samsrita Labs Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.28 | 0.58 | 1.9 | 1.43 | 0.01 | 0.02 | 0.02 | 0 | 0 | 0.02 | 0.02 |
| Operating profit | -0.58 | -1.13 | -2.44 | -2.19 | -0.91 | -0.41 | -0.99 | -0.25 | -0.26 | -8.71 | -8.75 |
| OPM % | -45.31% | -194.83% | -128.42% | -153.15% | -9,100.00% | -2,050.00% | -4,950.00% | — | — | -43,550.00% | -43,750.00% |
| Net profit | -1.31 | -1.05 | -2.33 | -1.98 | -0.77 | 1.49 | -0.71 | -0.26 | -0.28 | -8.16 | -8.16 |
| EPS (₹) | -1.28 | -0.89 | -1.69 | -1.34 | -0.52 | 1.01 | -0.48 | -0.18 | -0.19 | -3.59 | -3.58 |
TTM is the trailing twelve months to the most recent quarter.
Samsrita Labs Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 10.26 | 11.76 | 13.81 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 | 22.75 |
| Reserves | -2.39 | -0.40 | -1.61 | -3.03 | -3.66 | -1.58 | -2.29 | -2.55 | -2.84 | -11.00 |
| Borrowings | 6.50 | 6.81 | 7.92 | 8.58 | 2.34 | 2.74 | 2.08 | 2.20 | 2.43 | 1.66 |
| Other liabilities | 4.88 | 4.73 | 6.11 | 7.85 | 3.09 | 1.16 | 0.96 | 1.09 | 1.17 | 0.98 |
| Total liabilities | 19.25 | 22.90 | 26.23 | 28.21 | 16.58 | 17.13 | 15.56 | 15.55 | 15.57 | 14.39 |
| Fixed assets | 0.46 | 0.36 | 0.26 | 0.13 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| CWIP | 14.85 | 16.13 | 17.77 | 18.99 | 3.26 | 3.26 | 3.26 | 3.26 | 3.26 | 2.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 4.22 | 4.80 | 4.80 | 4.79 | 4.76 | 9.84 |
| Other assets | 3.93 | 6.40 | 8.19 | 9.08 | 9.08 | 9.06 | 7.49 | 7.49 | 7.55 | 2.55 |
| Total assets | 19.25 | 22.90 | 26.23 | 28.21 | 16.58 | 17.13 | 15.56 | 15.55 | 15.57 | 14.39 |
As reported by the company. Total assets equal total liabilities by construction.
Samsrita Labs Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -0.26 | -3.32 | -2.96 | -1.05 | -0.34 | -0.40 | 0.66 | -0.13 | -0.23 | -4.26 |
| Cash from investing | -1.09 | -1.19 | -1.55 | -1.11 | -0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 3.26 |
| Cash from financing | 1.27 | 4.83 | 4.19 | 2.17 | 0.55 | 0.40 | -0.67 | 0.13 | 0.22 | 2.63 |
| Net cash flow | -0.08 | 0.32 | -0.32 | 0.01 | -0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 1.63 |
| Free cash flow | -0.26 | -4.51 | -4.51 | -2.16 | -0.57 | -0.40 | 0.66 | -0.13 | -0.23 | -1.00 |
| CFO / operating profit | 45% | 294% | 121% | 48% | 37% | 98% | -67% | 52% | 88% | 49% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Samsrita Labs Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | -5.44% | -10.11% | -8.45% | -4.07% | 10.12% | -4.58% | -1.72% | -1.80% | -62.42% |
| Debtor days | 932.46 | 1,806.12 | 424.55 | 556.43 | 78,110.00 | 38,690.00 | 38,325.00 | — | — | 365.00 |
| Inventory days | 0.00 | — | — | — | — | 0.00 | 0.00 | — | — | 0.00 |
| Cash conversion cycle | 932.46 | 1,806.12 | 424.55 | 556.43 | 78,110.00 | 38,690.00 | 38,325.00 | — | — | 365.00 |
| Working capital days | -1,114.96 | -2,259.22 | -787.63 | -1,462.55 | 60,590.00 | 58,765.00 | 46,172.50 | — | — | -29,747.50 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Samsrita Labs Ltd shareholding pattern
Promoters held 25.44% at Jun 2026, down from 48.25% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 52.87% | 52.87% | 49.27% | 48.25% | 31.41% | 25.44% | 25.44% | 25.44% |
| Public | 47.13% | 47.14% | 50.72% | 51.74% | 68.58% | 74.56% | 74.57% | 74.56% |
| No. of shareholders | 2,740 | 2,578 | 2,608 | 2,478 | 2,441 | 2,436 | 2,441 | 2,506 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Samsrita Labs Ltd events
The next scheduled event is an EGM on 26 Oct 2026.
- EGMApproval for related party transactions including investment in S Labs Hygiene Care and unsecured loan
- Board meetingApproval of related party transactions and investment in S Labs Hygiene Care Private Limited
See the full results calendar for every Indian company reporting in the next 30 days.
Samsrita Labs Ltd corporate filings
- Samsrita Labs Ltd publishes newspaper publication under Regulation 30 (LODR) on October 4, 2026Company Updatelow impact
Cruxal's analysis: The company, with a market cap of approximately 26.18 crore, announced a newspaper…
Read the full analysis - Samsrita Labs Ltd publishes newspaper publication under Regulation 30 (LODR) on October 3, 2026Company Updatelow impact
Cruxal's analysis: The company, with a market cap of approximately 26.18 crore, announced a newspaper…
Read the full analysis - Samsrita Labs Limited Approves Material Related Party Transactions and Unsecured Loan from Non-Executive DirectorAGM/EGMhigh impact
Cruxal's analysis: Samsrita Labs Limited has filed notices for upcoming shareholder meetings, including an…
Read the full analysis - Samsrita Labs Limited Announces Related Party Investment and Working Capital Loan Ahead of EGMOthersmedium impact
Cruxal's analysis: Samsrita Labs Limited has announced a board-approved plan to invest up to 1 crore INR in…
Read the full analysis - Closure of Trading windowInsider Trading / SASTlow impact
- Samsrita Labs Ltd announces newspaper publication of financial disclosuresCompany Updatelow impact
Cruxal's analysis: Samsrita Labs Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…
Read the full analysis - Samsrita Labs Ltd files Statement of Deviation or Variation for quarter ended 30.06.2026Company Updatelow impact
Cruxal's analysis: Samsrita Labs Ltd has submitted a statement regarding the deviation or variation in the…
Read the full analysis - Samsrita Labs Limited Reports Continued Financial Losses for Quarter Ended June 2026Resultlow impact
Cruxal's analysis: Samsrita Labs Limited reported a standalone net loss of 31.47 lakh for the quarter ended…
Read the full analysis - Samsrita Labs Limited Shareholders Approve Capital Reduction and Strategic Business Alterations at 30th AGMAGM/EGMmedium impact
Cruxal's analysis: Samsrita Labs Limited has successfully concluded its 30th Annual General Meeting, where…
Read the full analysis - Samsrita Labs Limited Concludes 30th AGM; Shareholders Approve Capital Reduction and Related Party TransactionsAGM/EGMmedium impact
Cruxal's analysis: Samsrita Labs Limited has successfully concluded its 30th Annual General Meeting, where…
Read the full analysis - Samsrita Labs Limited schedules Board Meeting for August 13, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Samsrita Labs Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.